CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,232 Cr | ₹2,034 Cr | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr |
What is the latest Total Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,232 Cr |
| Mar2025 | ₹2,034 Cr |
| Mar2024 | ₹1,701 Cr |
| Mar2023 | ₹1,514 Cr |
| Mar2022 | ₹1,502 Cr |
How is Total Liabilities of CONCORD BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,232 Cr | 9.71 | |
| Mar2025 | ₹2,034 Cr | 19.61 | |
| Mar2024 | ₹1,701 Cr | 12.33 | |
| Mar2023 | ₹1,514 Cr | 0.81 | |
| Mar2022 | ₹1,502 Cr | - | |
Compare Total Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,210.9 Cr | -8% | -5.7% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -8% |
-5.7% |
-12.7% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses